Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Peskind

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Neurology|February 20, 1999
CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's diseaseS C Samuels, J M Silverman, D B Marin, et al.
Biological Psychiatry|August 28, 2001
Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorderE D Kanter, C W Wilkinson, A D Radant, et al.
Journal of the American Geriatrics Society|May 14, 1999
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case seriesA Lim, D Tsuang, W Kukull, et al.
Psychiatry Research|January 1, 1993
Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjectsR C Veith, N Lewis, J I Langohr, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 1, 1995
Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal agingE R Peskind, M A Raskind, D Wingerson, et al.
Archives of General Psychiatry|May 1, 1994
Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kineticsR C Veith, N Lewis, O A Linares, et al.
Neurology|August 19, 2007
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up studyG Li, I Sokal, J F Quinn, et al.
Neurology|August 29, 2007
Statin therapy is associated with reduced neuropathologic changes of Alzheimer diseaseG Li, E B Larson, J A Sonnen, et al.
Neurology|October 12, 2005
Serum cholesterol and risk of Alzheimer disease: a community-based cohort studyG Li, J B Shofer, W A Kukull, et al.
Archives of Neurology|December 11, 1999
The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case seriesD Tsuang, E B Larson, J Bowen, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Neurology|February 20, 1999
CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's diseaseS C Samuels, J M Silverman, D B Marin, et al.
Biological Psychiatry|August 28, 2001
Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorderE D Kanter, C W Wilkinson, A D Radant, et al.
Journal of the American Geriatrics Society|May 14, 1999
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case seriesA Lim, D Tsuang, W Kukull, et al.
Psychiatry Research|January 1, 1993
Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjectsR C Veith, N Lewis, J I Langohr, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 1, 1995
Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal agingE R Peskind, M A Raskind, D Wingerson, et al.
Archives of General Psychiatry|May 1, 1994
Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kineticsR C Veith, N Lewis, O A Linares, et al.
Neurology|August 19, 2007
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up studyG Li, I Sokal, J F Quinn, et al.
Neurology|August 29, 2007
Statin therapy is associated with reduced neuropathologic changes of Alzheimer diseaseG Li, E B Larson, J A Sonnen, et al.
Neurology|October 12, 2005
Serum cholesterol and risk of Alzheimer disease: a community-based cohort studyG Li, J B Shofer, W A Kukull, et al.
Archives of Neurology|December 11, 1999
The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case seriesD Tsuang, E B Larson, J Bowen, et al.
Pageof 8